We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Final Summary Report Sample Clauses

Final Summary Report. PR-36-1. BIO/WEST, Inc., Logan, Utah. 121 pp.
Final Summary Report. 26 11.3.1 CONTRACTOR shall submit, in a format approved by 27 ADMINISTRATOR, a Final Summary Report for each referred Participant and maintain 28 said Final Summary Report in the Participant’s case record. CONTRACTOR shall WCE0718-00 Page 33 of 41 May 1, 2018 EXHIBIT A 1 submit report to ADMINISTRATOR within fifteen (15) calendar days of last contact 2 with the Participant and/or Participant’s family and shall include, but are not 3 limited to, the following: 4 11.3.1.1 A summary of all Monthly Progress and Program 5 Reports specifying services and outcomes; and 6 11.3.1.2 A clear, concise identification of significant 7 issues regarding the Participant and/or Participant family’s needs.
Final Summary ReportThe Final Summary Report to be sent to Novartis by Supplier shall include the following information: *** *** Technical QA-Agreement between Novartis and Unigene for Supply of API batches Page 49 of 16 This Quality Assurance (QA) Agreement is between Novartis Pharma AG and Unigene Laboratories, Inc.. Address: Unigene 00 Xxxxxx Xxxxxx Boonton, New Jersey 07005 hereinafter called “Unigene” as contract acceptor and Novartis Pharma AG Technical Research and Development Xxxxxxxxxxxx 00 Xxxxx, XX-00000 Xxxxxxxxxxx hereinafter called “Novartis” as contract giver This quality agreement (“The Quality Agreement”) relates to the supply of *** (”the API”) from Unigene to Novartis. This Quality Agreement forms an annex to the supply agreement entered into between the parties relating to the supply of API by Unigene to Novartis (“the Supply Agreement”) It is intended that this QA agreement be consistent with the supply agreement. The Supply agreement shall be executed at the same time as this Agreement. For the avoidance of doubt regarding the requirement for confidentiality prior to the execution of a license agreement between the parties, Unigene and Novartis agree to use a level of confidentiality appropriate to the supply agreement. Novartis’s Quality department will be allowed to audit and to review batch records but it is expected that access to confidential information will be on a need-to-know basis only. For the avoidance of doubt, Unigene will be responsible for the “Release for Shipment” of its batches, providing assurance that the batch was manufactured in accordance with GMPs and tested and released according to the agreed specifications. Novartis will perform final Release and will be responsible for final GMP assessments and clinical use of the batch.
Final Summary ReportThe Team
Final Summary Report. All expected results shall be summarized and presented in the Final Summary Report to the City. The report shall include at a minimum the following: • Executive summaryStudy objectivesDescription of methodology • Inventory of all roads • Current pavement conditions for each street functional classification • Current pavement conditions in each Council District • Total amount of centerline and lane miles surveyed • Network OCI & PCI A draft of the Final Summary Report shall be presented at 75% completion of the data collection. The City will provide comments if additional information is needed that they want presented as part of the Final submittal. After review by the City, the Consultant will make all the necessary changes and submit a digital copy of the report. All documents and data produced for this project shall be considered property of the city. The consultant will also be available to attend the presentation of the data and the final summary report to the City of San Diego’s Council Committees and City Council to respond to any technical questions regarding the assessment and results.
Final Summary ReportDeveloper shall deliver a Final Summary Report which shall be comprehensive and include: ● Description of the delivered Prototype Instruments ● Review of testing results of the Prototype Instruments (only necessary if Phase V - Field Deployment & Third Party Testing has been completed) ● A summary description of Services performed. ● Identification of any “Subject Inventions” (as contemplated by Exhibit 4). ● Review of open issues identified at previous meeting(s) or in previous reports. Note: The Final Summary Report may be delivered before the Test Results & Final Summary Meeting if 2 months have passed after delivery of the Prototype Instruments and Documentation and Phase V has not been completed.
Final Summary Report. The IDNR shall prepare and submit a final written project report to the IDEM within twenty-seven (27) days of the close of the designated 2022 beach season. The report shall contain a summary of samples collected and the sample results, CSO notifications received and actions taken, precipitation data collected, and the beach advisories and closures issued throughout the designated 2022 beach season and the reasons for each advisory and/or closure.
Final Summary ReportThe records maintained under Paragraph A described above must be consolidated into a Final Summary Report, certified as correct by an authorized representative of the Design-Builder and submitted to the Resident Engineer thirty (30) days prior to completion with a copy to the Purchasing & Contracting Department. Attn: Compliance Section at 0000 Xxxxx Xxxxxx, Xxxxx 000, Xxx Xxxxx, XX 00000. A Notice of Completion and Acceptance will not be filed by the City until after its review of the Final Summary Report.

Related to Final Summary Report

  • Final Report The goal of this subtask is to prepare a comprehensive Final Report that describes the original purpose, approach, results, and conclusions of the work performed under this Agreement. The CAM will review the Final Report, which will be due at least two months before the Agreement end date. When creating the Final Report Outline and the Final Report, the Recipient must use the Style Manual provided by the CAM.

  • Management Report Promptly upon receipt thereof, copies of all detailed financial and management reports submitted to Borrower or any other Loan Party by independent auditors in connection with each annual or interim audit made by such auditors of the books of Borrower or any other Loan Party.

  • Progress Report By March 1 of each year, ***** will submit a written annual report to Stanford covering the preceding calendar year. The report will include information sufficient to enable Stanford to satisfy reporting requirements of the U.S. Government and for Stanford to ascertain progress by ***** toward meeting this Agreement’s diligence requirements. Each report will describe, where relevant: *****’s progress toward commercialization of Licensed Product, including work completed, key scientific discoveries, summary of work-in-progress, current schedule of anticipated events or milestones, market plans for introduction of Licensed Product, and significant corporate transactions involving Licensed Product. ***** will specifically describe how each Licensed Product is related to each Licensed Patent.

  • Problem Statement School bus fleets are aging, and our communities have poor air quality. Replacing school buses with zero emission school buses will address both of these issues.

  • CMI/RAI MDS Report Recognizing the mutual objective of quality resident care, the Employer agrees to meet through the Union Management Committee with the Union as soon as practicable after the receipt of the annual CMI/RAI MDS report. The Employer agrees to provide the Union with staffing levels, and staffing mix information; the impact of related payroll costs on staffing levels and a written notice of the CMI/RAI MDS report for the facility. The purpose of this meeting is to discuss the impact of the CMI/RAI MDS report on the staffing levels in the Home, quality resident care, and provide the Union with an opportunity to make representation in that regard. The parties shall meet as necessary to discuss other changes or workload issues. The parties may invite additional participants to attend the meeting to support constructive review and discussion.

  • Final Project Report Prepare a Final Project Report that addresses, to the extent feasible, comments made by the Grant Manager on the Draft Final Project Report. Submit one (1) reproducible master and an electronic copy of the final. Upload an electronic copy of the final report in pdf format to the FAAST system.

  • Daily Statement On each Banking Day on which any Participating Funds have an outstanding repurchase transaction, Repo Custodian shall deliver by facsimile to Custodian and to the Participating Funds a statement identifying the Securities held by Repo Custodian with respect to such repurchase transaction and the cash and Cash Collateral, if any, held by Repo Custodian in the Transaction Account, including a statement of the then current Market Value of such Securities and the amounts, if any, credited to the Transaction Account as of the close of trading on the previous Banking Day. Repo Custodian shall also deliver to Custodian and the Participating Funds such additional statements as the Participating Funds may reasonably request.

  • Project Summary The main objective of the LIFE GAIA Sense project is to demonstrate gaiasense, an innovative “Smart Farming” (SF) solution that aims at reducing the consumption of natural resources, as a way to protect the environment and support Circular Economy (CE) models. More specifically, this project will launch 18 demonstrators across Greece, Spain and Portugal covering 9 crops (olives, peaches, cotton, pistachio, potatoes, table tomatoes, industrial tomatoes, grapes, kiwi) in various terrain and microclimatic conditions. They will demonstrate an innovative method, based on high-end technology, which is suitable for being replicated and will be accessible and affordable to Farmers either as individuals or collectively through Agricultural Cooperatives. Moreover, LIFE GAIA Sense aims to promote resource efficiency practices in SMEs of the agricultural sector and eventually, contribute to the implementation of the Roadmap to a Resource Efficient Europe. This project will demonstrate a method on how the farmer will be able to decide either to use or avoid inputs (irrigation, fertilizers, pesticides etc.) in a most efficient way, without risking the annual production. The focus is on the resource consumption reduction side of CE, and the results will be both qualitatively and quantitatively, considering the resources’ efficiency in agricultural sector.

  • Monthly Statement The Contractor shall submit a statement to the Engineer at the end of each month, in a tabulated form approved by the Engineer, showing the amounts to which the Contractor considers himself to be entitled. The statement shall include the following items, as applicable; - the value of the Permanent Work executed up to the end of previous month - such an amount (not exceeding 75 percent of the value) as the Engineer may consider proper on account of materials for permanent work delivered by the Contractor in the site - such amount as the Engineer may consider fair and reasonable for any Temporary Works for which separate amounts are provided in the Bill of Quantities - adjustments under Clause 70 - any amount to be withheld under retention provisions of Sub-clause 60.3 - any other sum to which the Contractor may be entitled under the Contract If the Engineer disagrees with or cannot verify any part of the statement, the Contractor shall submit such further information as the Engineer may reasonably require and shall make such changes and corrections in the statement as may be directed by the Engineer. In cases where there is difference in opinion as to the value of any item, the Engineer’s view shall prevail.

  • Expense Summary The information set forth in the Prospectus in the Fee Table has been prepared in accordance with the requirements of Form N-2 and to the extent estimated or projected, such estimates or projections are reasonably believed to be attainable and reasonably based.